CERTCertara, Inc.

CERT Stock Price, Valuation & Chart | Certara, Inc.

Compare

$9.660+0.30 (+3.21%)

At close · 15 Oct 2026, 08:00 pm

Sector: Healthcare Industry: Medical - Healthcare Information Services

Overview Financials Dividends Ratios

CERT Historical price chart

CERT Key Stats

Market Capitalization1.47B

PE Ratio24.15

EPS0.4

Trading Volume1.66M

Today's High/Low9.7/9.25

Dividend Yield0.00

52 Week High/Low12.94/4.45

Shares Outstanding152.54M

CERT Financial Statement

CERT Analyst ratings

CERT Analysis & performance metrics

CERT Company profile

Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory…

Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company also provides related technology-enabled…

CERT Management team

Name

Position

John E. Gallagher IIICFO

SVice President, Principal Accounting Officer & Chief Financial Officer

Sheila Rocchio MBA

Chief Marketing Officer

Rona Anhalt

Chief Human Resources Officer

Ron DiSantis

Senior Vice President of Corporate Development

Frederic Yves Bois Ph.D., Pharm.D.

Senior Scientific Advisor, Head of Mechanistic Modeling & Member of Simcyp Advisory Board

William F. Feehery Ph.D.CEO

Chief Executive Officer & Director

Robert P. Aspbury Ph.D.

President of Certara Predictive Technologies

David Mitchell Ph.D.

Senior Vice President of Strategic Engagement

Name

Position

John E. Gallagher IIICFO

SVice President, Principal Accounting Officer & Chief Financial Officer

Sheila Rocchio MBA

Chief Marketing Officer

Rona Anhalt

Chief Human Resources Officer

Ron DiSantis

Senior Vice President of Corporate Development

Frederic Yves Bois Ph.D., Pharm.D.

Senior Scientific Advisor, Head of Mechanistic Modeling & Member of Simcyp Advisory Board

William F. Feehery Ph.D.CEO

Chief Executive Officer & Director

Robert P. Aspbury Ph.D.

President of Certara Predictive Technologies

David Mitchell Ph.D.

Senior Vice President of Strategic Engagement

Management Team

John E. Gallagher IIICFO

SVice President, Principal Accounting Officer & Chief Financial Officer

Sheila Rocchio MBA

Chief Marketing Officer

Rona Anhalt

Chief Human Resources Officer

Ron DiSantis

Senior Vice President of Corporate Development

Frederic Yves Bois Ph.D., Pharm.D.

Senior Scientific Advisor, Head of Mechanistic Modeling & Member of Simcyp Advisory Board

William F. Feehery Ph.D.CEO

Chief Executive Officer & Director

Robert P. Aspbury Ph.D.

President of Certara Predictive Technologies

David Mitchell Ph.D.

Senior Vice President of Strategic Engagement

Management

John E. Gallagher IIICFO

SVice President, Principal Accounting Officer & Chief Financial Officer

Sheila Rocchio MBA

Chief Marketing Officer

Rona Anhalt

Chief Human Resources Officer

Ron DiSantis

Senior Vice President of Corporate Development

Frederic Yves Bois Ph.D., Pharm.D.

Senior Scientific Advisor, Head of Mechanistic Modeling & Member of Simcyp Advisory Board

William F. Feehery Ph.D.CEO

Chief Executive Officer & Director

Robert P. Aspbury Ph.D.

President of Certara Predictive Technologies

David Mitchell Ph.D.

Senior Vice President of Strategic Engagement

Total 8 executives

CERT Frequently asked questions

What is Certara, Inc. (CERT) Stock Price?

Current stock price of Certara, Inc. (CERT) stock is $9.660. The stock price is +3.21% higher in the session. The intraday range can be seen from this page. Volume of Certara, Inc. (CERT) stock is 1.66M.

Last updated at 15 Oct 2026, 08:00 pm.

Why is the Certara, Inc. (CERT) stock price going up or down today?

The stock price of Certara, Inc. (CERT) can change with earnings, company news, and overall market sentiment. Certara, Inc. operates in the Healthcare / Medical - Healthcare Information Services market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Certara, Inc. stock expensive at its current price?

Whether Certara, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for CERT on this page is 24.15. EPS on this page is 0.40. Compare those figures with peers and growth expectations before deciding if the current Certara, Inc. price is justified.

How has the stock price of Certara, Inc. (CERT) performed historically?

Historical performance for Certara, Inc. (CERT) is shown on the price chart on this page. Review multi-period moves alongside volume to see how CERT reacted to past earnings and market events.

Should I buy Certara, Inc. (CERT) stock, at this price?

Buying Certara, Inc. (CERT) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.